SPY334.57+0.24 0.07%
DIA274.62+0.72 0.26%
IXIC11,010.98-97.09 -0.87%

Hearing Oppenheimer Initiates Coverage On NeuBase Therapeutics With An Outperform Rating, $14 Price Target

Benzinga · -